Q: WHAT IS THE PURPOSE OF THIS TRIAL?
A: The primary objective of this Phase III study is to evaluate the efficacy of Tf-CRM107 compared to best standard of care. Other objectives include an assessment of safety compared to best standard of care, and an evaluation of the differences in efficacy and safety of Tf-CRM107.



Back to FAQs